Germantown biopharma stock on the brink of delisting
June 03, 2019 at 14:55 PM EDT
The stem cell therapy could still move to appeal the decision before a Nasdaq panel.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.